Image Ben Hargreaves Patients Cell and gene therapies and the tricky question of patient s... Cell and gene therapies represent the cutting edge of pharma technology, but how are patients experiencing this treatment revolution? R&D Non-opioid painkillers: Another tool to fight the opioid epi... The opioid epidemic is still an ongoing problem and there is no single solution to bring it under control. Patients FDA wants to make the home a healthcare hub During the pandemic, the world became accustomed to carrying out more activities from the home, including healthcare needs. Market Access US-Chinese relations put the brakes on biotech cooperation The China-US trade war has spread to the biotech industry, as the US BIOSECURE Act looks to dampen Chinese influence on a range of services, including contract manufacturing. Load more results
Patients Cell and gene therapies and the tricky question of patient s... Cell and gene therapies represent the cutting edge of pharma technology, but how are patients experiencing this treatment revolution?
R&D Non-opioid painkillers: Another tool to fight the opioid epi... The opioid epidemic is still an ongoing problem and there is no single solution to bring it under control.
Patients FDA wants to make the home a healthcare hub During the pandemic, the world became accustomed to carrying out more activities from the home, including healthcare needs.
Market Access US-Chinese relations put the brakes on biotech cooperation The China-US trade war has spread to the biotech industry, as the US BIOSECURE Act looks to dampen Chinese influence on a range of services, including contract manufacturing.
News Pfizer takes 25-valent Prevnar follow-up into phase 3 Pfizer has upped the ante in the increasingly competitive market for pneumococcal vaccines with new data on a 25-valent candidate.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
